THE EFFECT OF MECLOFENOXATE WITH GINKGO-BILOBA EXTRACT OR ZINC ON LIPID PEROXIDE, SOME FREE-RADICAL SCAVENGERS AND THE CARDIOVASCULAR-SYSTEM OF AGED RATS
H. Alzuhair et al., THE EFFECT OF MECLOFENOXATE WITH GINKGO-BILOBA EXTRACT OR ZINC ON LIPID PEROXIDE, SOME FREE-RADICAL SCAVENGERS AND THE CARDIOVASCULAR-SYSTEM OF AGED RATS, Pharmacological research, 38(1), 1998, pp. 65-72
Aged rats are highly prone to many physiological changes such as blood
pressure and heart rate. These changes could be due to modification i
n membrane phospholipid composition of their blood vessels. Lipid pero
xide in vivo has been identified as a basic deteriorative reaction in
cellular mechanisms of aging in human. The effect of a nootropic drug,
meclofenoxate (MF) or its combination with extract of ginkgo biloba (
EGb-761) or zinc (Zn) on malondialdehyde (MDA) product as an index of
endogenous lipid peroxidation; phospholipid; glutathione (GSH) and pro
tein thiols (PrSHs) contents as well as superoxide dismutase (SOD) act
ivity in blood, brain, heart and liver of 24-month-old male rats was i
nvestigated. Aged rats were treated with MF once daily at oral doses o
f 100 mg kg-(1) body wt. alone or with either EGb at a dose of 150 mg
kg(-1) body wt. or Zn at 10.5 mg kg(-1) body wt, for 4 weeks. This stu
dy showed that aging caused a higher increment in MDA level of brain a
nd heart than liver and plasma accompanied with reduction in brain and
heart phospholipid contents as well as alteration of the antioxidant
systems as compared to 4-month-old rats. Treatment of aged rats with M
F alone or combined with either EGb or Zn caused improvement in the me
asured free radical scavengers especially in brain and heart tissues.
Our results also showed that both EGb and Zn induced a significant pot
ential effect of MF action on blood pressure and heart rate. The resul
ts were explained in the light of the antioxidant properties of EGb an
d Zn. Thus it is concluded that EGb and Zn have a beneficial role with
MF in diminishing cumulative oxidative changes in aging. (C) 1998 The
Italian Pharmacological Society.